Еvaluation of cardiovascular events in patients with ankylosing spondylitis after COVID-19

Please use this identifier to cite or link to this item: http://repository.tma.uz/xmlui/handle/1/2331

Full metadata record

DC Field	Value	Language
dc.contributor.author	Madina Rakhimova, Khalmurad Akhmedov, Sagdiyana Buranova, Laylo Tursunova	-
dc.date.accessioned	2022-09-29T10:51:55Z	-
dc.date.available	2022-09-29T10:51:55Z	-
dc.date.issued	2022	-
dc.identifier.issn	1308-5581	-
dc.identifier.uri	http://repository.tma.uz/xmlui/handle/1/2331	-
dc.description.abstract	Currently, there is no doubt about the importance of the role of impaired endothelial functional state in the development of vascular pathology in a number of diseases, including rheumatic. With the advent and large scale spread of a new coronavirus infection (COVID-19), a high rate of patient’s hospitalizations with ankylosing spondyloarthritis (AS) and the development of extrapulmonary complications, such as myocardial injuries, kidney damage and vascular thromboembolism, were noted. The development of this phenomenon confirms the connection with pronounced endothelial dysfunction and its damage. This article presents the results of evaluation of endothelial dysfunction in AS patients undergoing COVID-19	en_US
dc.language.iso	en	en_US
dc.publisher	Туркия	en_US
dc.relation.ispartofseries	УДК;	-
dc.subject	COVID-19, ankylosing spondylitis, еvaluation of cardiovascular	en_US
dc.title	Еvaluation of cardiovascular events in patients with ankylosing spondylitis after COVID-19	en_US
dc.type	Article	en_US
Appears in Collections:	Thesis, Articles

Files in This Item:

File	Description	Size	Format
1.6.1.Турсунова Л.Д..pdf	Еvaluation of cardiovascular events in patients with ankylosing spondylitis after COVID-19	329.58 kB	Adobe PDF	View/Open

DSpace JSPUI